neothylline
Pharmaranks rates Neothylline 2.7/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Neothylline (Dyphylline) is a medication used to treat Asthma, Bronchitis.
Dyphylline · by Teva
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Dyphylline
- Form
- Tablet, Injectable, Elixir
- Strength
- Dyphylline 160MG/15ML · Dyphylline 200MG · Dyphylline 400MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- asthma, bronchitis
- Manufacturer
- Teva
- FDA application
- NDA007794
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Tablet, Injectable and Elixir
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Neothylline treat?
- Neothylline (Dyphylline) may be used to treat asthma, bronchitis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Neothylline rated?
- pharmaranks gives Neothylline a composite score of 2.7 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Neothylline?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Neothylline. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Neothylline?
- Neothylline is marketed by Teva. You can see Teva's full profile, rating, and other products on pharmaranks.
- Is Neothylline a brand-name or generic drug?
- Neothylline is a brand-name product with the active ingredient Dyphylline.
- Is Neothylline available over the counter?
- No. Neothylline is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Neothylline come in?
- Neothylline is currently marketed as tablet, injectable and elixir, per the FDA's National Drug Code Directory.
- Is Neothylline FDA-registered?
- Neothylline is on record with the U.S. FDA under application number NDA007794. You can verify this on its official FDA label.
- Has Neothylline been recalled by the FDA?
- Neothylline has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Neothylline safe?
- There's no single safe-or-not verdict. pharmaranks gives Neothylline a recall-safety score of 54/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about DYPHYLLINE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 174 reports naming DYPHYLLINE — the active ingredient in Neothylline, and the FDA flagged 79% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- dyspnoea10 reports
- anxiety9 reports
- chest pain9 reports
- pneumonia9 reports
- dizziness8 reports
- nausea8 reports
- rash8 reports
- hypersensitivity7 reports
Read these as a signal, not a rate. A report does not mean DYPHYLLINE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
accolate
Zafirlukast
atrovent hfa
Ipratropium Bromide
cefixime
Cefixime
cromolyn sodium
Cromolyn Sodium
exdensur
Depemokimab-Ulaa
flunisolide
Flunisolide
Compare Neothylline head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
neothylline
54/100